3-Methoxytyramine as an indicator of dopaminergic manipulation in the equine athlete

被引:6
|
作者
Wynne, PM
Vine, JH
Amiet, RG
机构
[1] Racing Analyt Serv Ltd, Flemington, Vic 3031, Australia
[2] RMIT Univ, Dept Appl Chem, Melbourne, Vic 3001, Australia
关键词
3-methoxytyramine; dopamine manipulation; regulatory threshold;
D O I
10.1016/j.jchromb.2004.03.078
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The influence of sampling variables on the concentration of the dopamine metabolites 3-methoxytyramine (3MT), dihydroxyphenylacetic acid (DOPAC) and homovanilic acid (HVA) was examined in equine urine. A logarithmic transformation of the data for all horses gave distribution which approximated the normal distributions for each metabolite. The mean urinary concentration of 3MT in horses was 214 ng/mL and the application of a threshold with a probability of 1 in 10,000 gave an actionable level of 4 mug/mL. Environmental variables were not forensically significant in determining the population distribution. HVA was not found to be a reliable indicator of dopamine or levodopa administration. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 50 条
  • [21] Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma
    Verly, Iedan R. N.
    Matser, Yvette A. H.
    Leen, Rene
    Meinsma, Rutger
    Fiocco, Marta
    Koster, Jan
    Volckmann, Richard
    Savci-Heijink, Dilara
    Cangemi, Giuliana
    Barco, Sebastiano
    Valentijn, Linda J.
    Tytgat, Godelieve A. M.
    van Kuilenburg, Andre B. P.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [22] 3-METHOXYTYRAMINE, A CATECHOLAMINE CATABOLITE REGULARLY PRESENT IN HUMAN URINE
    KASER, H
    EXPERIENTIA, 1970, 26 (02): : 138 - +
  • [23] Urinary 3-Methoxytyramine is a Biomarker for MYC Activity in Patients with Neuroblastoma
    Verly, I.
    Matser, Y.
    Leen, R.
    Meinsma, R.
    Fiocco, M.
    Koster, J.
    Volckmann, R.
    Savci-Heijink, D.
    Cangemi, G.
    Barco, S.
    Conte, M.
    Garaventa, A.
    Valentijn, L.
    Tytgat, L.
    Kuilenburg, A.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S48 - S48
  • [24] DIFFERENTIAL-EFFECTS OF CERTAIN DOPAMINERGIC DRUGS ON THE STRIATAL CONCENTRATION OF DOPAMINE METABOLITES, WITH SPECIAL REFERENCE TO 3-METHOXYTYRAMINE
    PONZIO, F
    ACHILLI, G
    PEREGO, C
    ALGERI, S
    NEUROSCIENCE LETTERS, 1981, 27 (01) : 61 - 67
  • [25] Binding of dopamine and 3-methoxytyramine as L-DOPA metabolites to human α2-adrenergic and dopaminergic receptors
    Alachkar, Amal
    Brotchie, Jonathan M.
    Jones, Owen T.
    NEUROSCIENCE RESEARCH, 2010, 67 (03) : 245 - 249
  • [26] ON THE SIGNIFICANCE OF 3-METHOXYTYRAMINE, A DOPAMINE METABOLITE IN THE RAT-BRAIN
    VULTO, AG
    WESTENBERG, HGM
    VERSTEEG, DHG
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1983, 5 (05) : 265 - 265
  • [27] MASS FRAGMENTOGRAPHIC ASSAY OF 3-METHOXYTYRAMINE IN RAT-BRAIN
    GALLI, CL
    CATTABENI, F
    EROS, T
    SPANO, PF
    ALGERI, S
    DIGIULIO, A
    GROPPETTI, A
    JOURNAL OF NEUROCHEMISTRY, 1976, 27 (03) : 795 - 798
  • [28] URINARY-EXCRETION OF 3-METHOXYTYRAMINE IN PARKINSONS-DISEASE
    SIIRTOLA, T
    SONNINEN, V
    RINNE, UK
    ACTA NEUROLOGICA SCANDINAVICA, 1976, 54 (01): : 117 - 118
  • [29] Joint Mobilization and Manipulation for the Equine Athlete
    Haussler, Kevin K.
    VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2016, 32 (01) : 87 - +
  • [30] EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3-METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN
    CARLSSON, A
    LINDQVIST, M
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1963, 20 (02): : 140 - &